Breast cancer risk assessment and risk distribution in 3,491 Slovenian women invited for screening at the age of 50; a population-based cross-sectional study.
IBIS
Tyrer-Cuzick model
breast cancer screening
breast density
personalised screening
risk assessment
Journal
Radiology and oncology
ISSN: 1581-3207
Titre abrégé: Radiol Oncol
Pays: Poland
ID NLM: 9317213
Informations de publication
Date de publication:
01 09 2023
01 09 2023
Historique:
received:
01
06
2023
accepted:
06
07
2023
medline:
6
9
2023
pubmed:
4
9
2023
entrez:
4
9
2023
Statut:
epublish
Résumé
The evidence shows that risk-based strategy could be implemented to avoid unnecessary harm in mammography screening for breast cancer (BC) using age-only criterium. Our study aimed at identifying the uptake of Slovenian women to the BC risk assessment invitation and assessing the number of screening mammographies in case of risk-based screening. A cross-sectional population-based study enrolled 11,898 women at the age of 50, invited to BC screening. The data on BC risk factors, including breast density from the first 3,491 study responders was collected and BC risk was assessed using the Tyrer-Cuzick algorithm (version 8) to classify women into risk groups (low, population, moderately increased, and high risk group). The number of screening mammographies according to risk stratification was simulated. 57% (6,785) of women returned BC risk questionnaires. When stratifying 3,491 women into risk groups, 34.0% were assessed with low, 62.2% with population, 3.4% with moderately increased, and 0.4% with high 10-year BC risk. In the case of potential personalised screening, the number of screening mammographies would drop by 38.6% compared to the current screening policy. The study uptake showed the feasibility of risk assessment when inviting women to regular BC screening. 3.8% of Slovenian women were recognised with higher than population 10-year BC risk. According to Slovenian BC guidelines they may be screened more often. Overall, personalised screening would decrease the number of screening mammographies in Slovenia. This information is to be considered when planning the pilot and assessing the feasibility of implementing population risk-based screening.
Sections du résumé
BACKGROUND
The evidence shows that risk-based strategy could be implemented to avoid unnecessary harm in mammography screening for breast cancer (BC) using age-only criterium. Our study aimed at identifying the uptake of Slovenian women to the BC risk assessment invitation and assessing the number of screening mammographies in case of risk-based screening.
PATIENTS AND METHODS
A cross-sectional population-based study enrolled 11,898 women at the age of 50, invited to BC screening. The data on BC risk factors, including breast density from the first 3,491 study responders was collected and BC risk was assessed using the Tyrer-Cuzick algorithm (version 8) to classify women into risk groups (low, population, moderately increased, and high risk group). The number of screening mammographies according to risk stratification was simulated.
RESULTS
57% (6,785) of women returned BC risk questionnaires. When stratifying 3,491 women into risk groups, 34.0% were assessed with low, 62.2% with population, 3.4% with moderately increased, and 0.4% with high 10-year BC risk. In the case of potential personalised screening, the number of screening mammographies would drop by 38.6% compared to the current screening policy.
CONCLUSIONS
The study uptake showed the feasibility of risk assessment when inviting women to regular BC screening. 3.8% of Slovenian women were recognised with higher than population 10-year BC risk. According to Slovenian BC guidelines they may be screened more often. Overall, personalised screening would decrease the number of screening mammographies in Slovenia. This information is to be considered when planning the pilot and assessing the feasibility of implementing population risk-based screening.
Identifiants
pubmed: 37665745
pii: raon-2023-0039
doi: 10.2478/raon-2023-0039
pmc: PMC10476908
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
337-347Informations de copyright
© 2023 Katja Jarm et al., published by Sciendo.
Références
J Med Genet. 2022 Dec;59(12):1206-1218
pubmed: 36162851
Cancer Epidemiol Biomarkers Prev. 2021 Mar;30(3):469-473
pubmed: 33335023
Clin Imaging. 2022 Mar;83:21-27
pubmed: 34952487
Stat Sci. 2020 Mar 3;35(1):14-30
pubmed: 32226220
Breast Cancer Res Treat. 2019 Jun;175(2):519-523
pubmed: 30796654
Radiol Oncol. 2020 Jul 2;54(3):335-340
pubmed: 32614783
Breast Cancer Res. 2015 Dec 01;17(1):147
pubmed: 26627479
NPJ Breast Cancer. 2017 Sep 13;3:34
pubmed: 28944288
BMC Cancer. 2022 May 6;22(1):507
pubmed: 35524202
PLoS One. 2021 Oct 8;16(10):e0258343
pubmed: 34624045
J Med Screen. 2021 Dec;28(4):389-404
pubmed: 33632023
J Natl Cancer Inst. 2014 Sep 12;106(10):
pubmed: 25217577
J Natl Cancer Inst. 1999 Sep 15;91(18):1541-8
pubmed: 10491430
Br J Cancer. 2016 Apr 26;114(9):1045-52
pubmed: 27022688
Stat Med. 2004 Apr 15;23(7):1111-30
pubmed: 15057881
Int J Environ Res Public Health. 2022 Aug 21;19(16):
pubmed: 36012059
Prog Mol Biol Transl Sci. 2017;151:1-32
pubmed: 29096890
Radiol Oncol. 2017 Feb 22;51(1):47-55
pubmed: 28265232
Acta Oncol. 2018 May;57(5):595-603
pubmed: 29164969
AJR Am J Roentgenol. 2012 Mar;198(3):W292-5
pubmed: 22358028
N Engl J Med. 2007 Jan 18;356(3):227-36
pubmed: 17229950
PLoS One. 2019 Dec 16;14(12):e0226352
pubmed: 31841563
Nat Rev Clin Oncol. 2020 Nov;17(11):687-705
pubmed: 32555420
Zdr Varst. 2020 Oct 18;59(4):211-218
pubmed: 33133277